Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-12
DOI
10.3389/fneur.2020.00556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation
- (2020) Gul Ozbey et al. Pharmacological Reports
- Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson’s Disease
- (2019) Liping Zhang et al. Journal of Parkinsons Disease
- Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study
- (2019) Seyed-Mohammad Fereshtehnejad et al. BRAIN
- Dysfunction of Cellular Proteostasis in Parkinson’s Disease
- (2019) Šárka Lehtonen et al. Frontiers in Neuroscience
- Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus
- (2019) Qian Shi et al. BMJ Open
- AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR
- (2019) Caterina Collodet et al. FASEB JOURNAL
- Update of the MDS research criteria for prodromal Parkinson's disease
- (2019) Sebastian Heinzel et al. MOVEMENT DISORDERS
- Focused ultrasound in Parkinson's disease: A twofold path toward disease modification
- (2019) Guglielmo Foffani et al. MOVEMENT DISORDERS
- Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson’s Disease: A Systematic Review
- (2019) Fauze Camargo Maluf et al. Parkinsons Disease
- Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK/CREB-mediated histone acetylation
- (2019) Wenting Fang et al. JOURNAL OF AFFECTIVE DISORDERS
- Neuroprotection in Parkinson’s disease: facts and hopes
- (2019) András Salamon et al. JOURNAL OF NEURAL TRANSMISSION
- Neuroprotective effect of metformin on dopaminergic neurodegeneration and α-synuclein aggregation in C. elegans model of Parkinson’s disease
- (2019) Nada Saewanee et al. NEUROSCIENCE RESEARCH
- Diabetes mellitus and Parkinson disease
- (2018) Gennaro Pagano et al. NEUROLOGY
- Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
- (2018) Xian-Si Zeng et al. Frontiers in Aging Neuroscience
- The Parkinson Pandemic—A Call to Action
- (2018) E. Ray Dorsey et al. JAMA Neurology
- The Therapeutic Potential of Metformin in Neurodegenerative Diseases
- (2018) Carola Rotermund et al. Frontiers in Endocrinology
- Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
- (2018) Tze Pin Ng et al. JOURNAL OF ALZHEIMERS DISEASE
- Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
- (2018) Jared M. Campbell et al. JOURNAL OF ALZHEIMERS DISEASE
- Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism
- (2018) Yufeng Lin et al. Frontiers in Aging Neuroscience
- Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
- (2018) Amy M. Smith et al. MOVEMENT DISORDERS
- Earlier onset of motor complications in Parkinson's patients with comorbid diabetes mellitus
- (2018) Norlinah Mohamed Ibrahim et al. MOVEMENT DISORDERS
- Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells
- (2017) Antonella Izzo et al. HUMAN MOLECULAR GENETICS
- Neuroprotective Surgical Strategies in Parkinson’s Disease: Role of Preclinical Data
- (2017) Napoleon Torres et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease
- (2017) Marissa Ong et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
- (2017) Tim E. Moors et al. Molecular Neurodegeneration
- Glitazone use associated with reduced risk of Parkinson's disease
- (2017) Brage Brakedal et al. MOVEMENT DISORDERS
- Parkinson disease: Exenatide – a drug for diabetes and Parkinson disease?
- (2017) Joseph Jankovic Nature Reviews Neurology
- Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease
- (2017) Nikita Katila et al. NEUROPHARMACOLOGY
- Activation of the ATF2/CREB-PGC-1α pathway by metformin leads to dopaminergic neuroprotection
- (2017) Hojin Kang et al. Oncotarget
- Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA
- (2017) Yuanyuan Li et al. Frontiers in Aging Neuroscience
- Is Exenatide a Treatment for Parkinson’s Disease?
- (2017) Dilan Athauda et al. Journal of Parkinsons Disease
- Parkinson disease
- (2017) Werner Poewe et al. Nature Reviews Disease Primers
- Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments
- (2017) Panchanan Maiti et al. Translational Neurodegeneration
- Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease
- (2016) M. Petrou et al. ACADEMIC RADIOLOGY
- Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium
- (2016) C. R. Triggle et al. Acta Physiologica
- Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease
- (2016) Henrik H Hansen et al. BRAIN RESEARCH
- Metformin Activates AMPK through the Lysosomal Pathway
- (2016) Chen-Song Zhang et al. Cell Metabolism
- Metformin as a Tool to Target Aging
- (2016) Nir Barzilai et al. Cell Metabolism
- Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission
- (2016) Qilong Wang et al. DIABETES
- Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes
- (2016) Caterina Palleria et al. FRONTIERS IN NEUROENDOCRINOLOGY
- AMPK governs lineage specification through Tfeb-dependent regulation of lysosomes
- (2016) Nathan P. Young et al. GENES & DEVELOPMENT
- Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives
- (2016) Sumit Sarkar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson’s Disease via Autophagy and Mitochondrial ROS Clearance
- (2016) Ming Lu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Parkinson’s: a syndrome rather than a disease?
- (2016) Nataliya Titova et al. JOURNAL OF NEURAL TRANSMISSION
- Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells
- (2016) Jaishree Jalewa et al. JOURNAL OF NEUROCHEMISTRY
- Mitochondrial dysfunction in Parkinson's disease
- (2016) Anindita Bose et al. JOURNAL OF NEUROCHEMISTRY
- Genetics of Parkinson's disease
- (2016) Christina M. Lill MOLECULAR AND CELLULAR PROBES
- Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation
- (2016) Milena Pinto et al. Molecular Neurodegeneration
- Unravelling the nonmotor mysteries of Parkinson disease
- (2016) K. Ray Chaudhuri et al. Nature Reviews Neurology
- A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson’s disease by reducing chronic inflammation in the brain
- (2016) Lijun Cao et al. NEUROREPORT
- Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson’s disease
- (2016) Istvan Horvath et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study
- (2015) Ronald B. Postuma et al. ANNALS OF NEUROLOGY
- AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease
- (2015) Rafael P. Vázquez-Manrique et al. HUMAN MOLECULAR GENETICS
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Prediagnostic presentations of Parkinson's disease in primary care: a case-control study
- (2015) Anette Schrag et al. LANCET NEUROLOGY
- Metformin improves anxiety-like behaviors through AMPK-dependent regulation of autophagy following transient forebrain ischemia
- (2015) Alireza Sarkaki et al. METABOLIC BRAIN DISEASE
- Disease-modifying strategies for Parkinson's disease
- (2015) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- MDS clinical diagnostic criteria for Parkinson's disease
- (2015) Ronald B. Postuma et al. MOVEMENT DISORDERS
- MDS research criteria for prodromal Parkinson's disease
- (2015) Daniela Berg et al. MOVEMENT DISORDERS
- Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats
- (2015) A.A. Martinez et al. NEUROBIOLOGY OF DISEASE
- Parkinson risk in idiopathic REM sleep behavior disorder: Preparing for neuroprotective trials
- (2015) R. B. Postuma et al. NEUROLOGY
- Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD
- (2015) P. Mahlknecht et al. NEUROLOGY
- Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice
- (2015) Zhili Ren et al. NEUROPHARMACOLOGY
- Low alpha-synuclein levels in the blood are associated with insulin resistance
- (2015) Gerardo Rodriguez-Araujo et al. Scientific Reports
- The Concept of Prodromal Parkinson’s Disease
- (2015) Philipp Mahlknecht et al. Journal of Parkinsons Disease
- Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine
- (2014) Janaína K. Barbiero et al. BEHAVIOURAL BRAIN RESEARCH
- Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy
- (2014) Teng Jiang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls
- (2014) C. A. Bannister et al. DIABETES OBESITY & METABOLISM
- Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
- (2014) Joong Sup Shim et al. International Journal of Biological Sciences
- Type 2 Diabetes and Antidiabetic Medications in Relation to Dementia Diagnosis
- (2014) Chin Cheng et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia
- (2014) Ghorbangol Ashabi et al. METABOLIC BRAIN DISEASE
- Activation of AMP-activated protein kinase by metformin protects against global cerebral ischemia in male rats: Interference of AMPK/PGC-1α pathway
- (2014) Ghorbangol Ashabi et al. METABOLIC BRAIN DISEASE
- The ongoing pursuit of neuroprotective therapies in Parkinson disease
- (2014) Dilan Athauda et al. Nature Reviews Neurology
- Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice
- (2014) S.P. Patil et al. NEUROSCIENCE
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
- (2014) Nicolaas I. Bohnen et al. PARKINSONISM & RELATED DISORDERS
- Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide
- (2014) Krzysztof Łabuzek et al. Pharmacological Reports
- Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2
- (2014) W. De Haes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metformin lowers Ser-129 phosphorylated α-synuclein levels via mTOR-dependent protein phosphatase 2A activation
- (2014) B I Pérez-Revuelta et al. Cell Death & Disease
- PINK1 deficiency in -cells increases basal insulin secretion and improves glucose tolerance in mice
- (2014) E. Deas et al. Open Biology
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism
- (2013) Filipe Cabreiro et al. CELL
- Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes
- (2013) A.J. Scheen et al. DIABETES & METABOLISM
- Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice
- (2013) Ling Wang et al. EXPERIMENTAL NEUROLOGY
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study
- (2013) Alex Iranzo et al. LANCET NEUROLOGY
- ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase
- (2013) Ryan C. Russell et al. NATURE CELL BIOLOGY
- Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series
- (2013) Carlos H. Schenck et al. SLEEP MEDICINE
- Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group
- (2013) C.H. Schenck et al. SLEEP MEDICINE
- Metformin: an old but still the best treatment for type 2 diabetes
- (2013) Lilian Beatriz Aguayo Rojas et al. Diabetology & Metabolic Syndrome
- The Role of Autophagy in Parkinson's Disease
- (2013) M. A. Lynch-Day et al. Cold Spring Harbor Perspectives in Medicine
- Parkinson's disease, insulin resistance and novel agents of neuroprotection
- (2012) Iciar Aviles-Olmos et al. BRAIN
- Metformin Activates an Atypical PKC-CBP Pathway to Promote Neurogenesis and Enhance Spatial Memory Formation
- (2012) Jing Wang et al. Cell Stem Cell
- AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson's Disease
- (2012) C.-H. Ng et al. JOURNAL OF NEUROSCIENCE
- The Lewy Body in Parkinson’s Disease and Related Neurodegenerative Disorders
- (2012) Koichi Wakabayashi et al. MOLECULAR NEUROBIOLOGY
- The significance of defining preclinical or prodromal Parkinson's disease
- (2012) C. Warren Olanow et al. MOVEMENT DISORDERS
- Hippocampal abnormalities and memory deficits in Parkinson disease: A multimodal imaging study
- (2012) G. A. Carlesimo et al. NEUROLOGY
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes
- (2012) Deepak Jain et al. Journal of Molecular Cell Biology
- Metformin slows down aging and extends life span of female SHR mice
- (2011) Vladimir N. Anisimov et al. CELL CYCLE
- Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo
- (2011) Vladimir N. Anisimov et al. CELL CYCLE
- Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease
- (2011) Giuseppa Mudò et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Diabetes and Risk of Parkinson's Disease: A systematic review and meta-analysis
- (2011) E. Cereda et al. DIABETES CARE
- Insulin resistance impairs nigrostriatal dopamine function
- (2011) J.K. Morris et al. EXPERIMENTAL NEUROLOGY
- Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease
- (2011) Benedicte Ballanger et al. MOVEMENT DISORDERS
- Why have we failed to achieve neuroprotection in Parkinson's disease?
- (2010) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Lactic Acidosis Induced by Metformin
- (2010) Jean-Daniel Lalau DRUG SAFETY
- CREB: a multifaceted regulator of neuronal plasticity and protection
- (2010) Kensuke Sakamoto et al. JOURNAL OF NEUROCHEMISTRY
- Missing pieces in the Parkinson's disease puzzle
- (2010) Jose A Obeso et al. NATURE MEDICINE
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- AMP-activated protein kinase is activated in Parkinson’s disease models mediated by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- (2009) Jae-Sun Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Etiology and Pathogenesis of Parkinson Disease
- (2009) Anthony H.V. Schapira NEUROLOGIC CLINICS
- Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF
- (2009) G. C. O'Keeffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glucagon-like peptide 1 receptor stimulation by exendin-4 reverses key deficits in distinct rodent models of Parkinson's disease
- (2008) Alexander Harkavyi et al. Journal of Neuroinflammation
- Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
- (2008) R. B. Postuma et al. NEUROLOGY
- Selective hyposmia in Parkinson disease: Association with hippocampal dopamine activity
- (2008) Nicolaas I. Bohnen et al. NEUROSCIENCE LETTERS
- Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease
- (2007) Göran Bertilsson et al. JOURNAL OF NEUROSCIENCE RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started